The link between LL-37 and hypercoagulation was also tested in mice injected with the cathelicidins LL-37 and CRAMP, which presented increased occurrence of thrombosis, whereas deletion of the cathelicidin gene inhibited thrombosis in the animals (Duan et al., 2022). This evidence concerns the gene CAMP and deep vein thrombosis.